Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy development

This publication has 75 references indexed in Scilit:

• The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors
  Molecular Therapy, 2003
• Gene Transfer to Ovarian Cancer Versus Normal Tissues with Fiber-Modified Adenoviruses
  Molecular Therapy, 2002
• Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ
  The Journal of Gene Medicine, 2002
• Role of Hepatocyte Direct Hyperplasia in Lentivirus-Mediated Liver TransductionIn Vivo
  Human Gene Therapy, 2002
• Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion
  Gene Therapy, 2002
• CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors
  Gene Therapy, 2001
• Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response
  Gene Therapy, 2001
• Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods
  The FASEB Journal, 2000
• Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits
  The Journal of Gene Medicine, 1999
• Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse
  Cancer Gene Therapy, 1999